US 7217738
β2-adrenergic receptor agonists
granted A61KA61K31/137A61K31/167
Quick answer
US patent 7217738 (β2-adrenergic receptor agonists) held by Theravance, Inc. expires Mon May 10 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue May 15 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 10 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/137, A61K31/167, A61K31/403, A61K31/404